Skip to main content
. Author manuscript; available in PMC: 2020 Feb 3.
Published in final edited form as: Neurobiol Dis. 2019 May 17;129:118–129. doi: 10.1016/j.nbd.2019.05.009

Fig. 5. Characterization of differentiated patient-derived induced pluripotent stem cells.

Fig. 5.

(A) Representative images of differentiated control (CTR21n2) and HD (HD109n1) iPSCs. Cells were stained with Hoechst to visualize nuclei and MAP2 to visualize projections and the medium spiny neuron marker DARPP-32. Scale bar: 150 μm.

(B) Representative images of differentiated control (CTR21n2) and HD (HD109n1) iPSCs. Cells were stained with Hoechst to visualize nuclei and MAP2 to visualize projections and the medium spiny neuron marker CTIP2. Scale bar: 150 μm.